Regulus Therapeutics Announces Positive Topline Data from the Third Cohort of Patients in its Phase 1b...
Regulus Therapeutics Announces Expected Addition to the Russell 3000® and Russell 2000® Indexes PR...
Regulus Therapeutics Announces Promotion of Rekha Garg, M.D., M.S., to Chief Medical Officer PR Newswire SAN...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.